IN2014MU00043A - - Google Patents

Download PDF

Info

Publication number
IN2014MU00043A
IN2014MU00043A IN43MU2014A IN2014MU00043A IN 2014MU00043 A IN2014MU00043 A IN 2014MU00043A IN 43MU2014 A IN43MU2014 A IN 43MU2014A IN 2014MU00043 A IN2014MU00043 A IN 2014MU00043A
Authority
IN
India
Prior art keywords
enhancer
vilazodone
pharmaceutically acceptable
pharmaceutical composition
acceptable salt
Prior art date
Application number
Other languages
English (en)
Inventor
Gour Mukherji
Vijayendrakumar Virendrakumarji Redasani
Amol Ashoklal Jain
Prutha Shrikrishna Gaitonde
Vaibhavi Ankur Shah
Original Assignee
Inventia Healthcare Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inventia Healthcare Private Ltd filed Critical Inventia Healthcare Private Ltd
Priority to IN43MU2014 priority Critical patent/IN2014MU00043A/en
Publication of IN2014MU00043A publication Critical patent/IN2014MU00043A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN43MU2014 2014-01-06 2014-01-06 IN2014MU00043A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN43MU2014 IN2014MU00043A (es) 2014-01-06 2014-01-06

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN43MU2014 IN2014MU00043A (es) 2014-01-06 2014-01-06

Publications (1)

Publication Number Publication Date
IN2014MU00043A true IN2014MU00043A (es) 2015-08-21

Family

ID=54393299

Family Applications (1)

Application Number Title Priority Date Filing Date
IN43MU2014 IN2014MU00043A (es) 2014-01-06 2014-01-06

Country Status (1)

Country Link
IN (1) IN2014MU00043A (es)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3360543A1 (en) * 2017-02-13 2018-08-15 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical compositions of vilazodone hydrochloride
EP3360542A1 (en) * 2017-02-13 2018-08-15 Sanovel Ilac Sanayi ve Ticaret A.S. Tablet forms of vilazodone hydrochloride

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3360543A1 (en) * 2017-02-13 2018-08-15 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical compositions of vilazodone hydrochloride
EP3360542A1 (en) * 2017-02-13 2018-08-15 Sanovel Ilac Sanayi ve Ticaret A.S. Tablet forms of vilazodone hydrochloride

Similar Documents

Publication Publication Date Title
NZ734233A (en) Pharmaceutical compositions comprising meloxicam
HK1243999A1 (zh) 新型3-吲哚取代的衍生物、藥物組合物及使用方法
MX2016016593A (es) Nuevos derivados de aminoalquibenzotiazepina y usos de los mismos.
PH12017502431A1 (en) Pharmaceutical formulations comprising tenofovir and emtrictabine
EP3102188A4 (en) Novel disintegration systems for pharmaceutical dosage forms
MX2017016802A (es) Formulaciones farmaceuticas.
PH12016501841A1 (en) Immunosuppressant formulation
PH12017501084A1 (en) Insulin glargine/lixisenatide fixed ratio formulation
IN2014MU00303A (es)
IL252897A0 (en) Indanyl compounds, pharmaceutical preparations and their medical uses
UA118474C2 (uk) (s)-пірліндол та його фармацевтично прийнятні солі для застосування в медицині
CY1119522T1 (el) (r)- πιρλινδολη και τα φαρμακευτικως αποδεκτα αλατα αυτης για χρηση στην ιατρικη
EP3456711A4 (en) CASPASE INHIBITOR AND PHARMACEUTICAL COMPOSITION, USE AND THERAPEUTIC METHOD THEREFOR
IN2014MU00043A (es)
MX2021003230A (es) Composiciones farmaceuticas que comprenden meloxicam.
EP3697393A4 (en) PHARMACEUTICAL DOSAGE FORMS
EA201991007A1 (ru) Твердые фармацевтические композиции на основе гидрохлорида луразидона для перорального применения
EP3624809A4 (en) PHARMACEUTICAL AGENTS, COMPOSITIONS AND RELATED PROCESSES
IN2013MU03370A (es)
GEP20196989B (en) Pharmaceutical composition comprising bisoprolol and perindoril
IN2013MU02015A (es)
ZA201803722B (en) Pharmaceutical composition containing, as active ingredient, 7-azaindolin-2-one derivative or pharmaceutically acceptable salt thereof
EP3675842A4 (en) PHARMACEUTICAL DOSAGE FORMS
IN2014CH01195A (es)
IN2014MU01326A (es)